Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 8,980 shares at $57.82 ($513K) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $513k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.12 | 2,209 | $124K | 24.2% |
| 2 | $56.12 | 2,209 | $124K | 24.2% |
| 3 | $57.82 | 3,800 | $220K | 42.9% |
| 4 | $58.63 | 495 | $29K | 5.7% |
| 5 | $59.46 | 267 | $16K | 3.1% |
| Total | $57.08 avg | 8,980 |
| $513K |
| 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |